The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration
Abstract
Myocardial infarction causes cardiac tissue damage and the release of damage-associated molecular patterns leads to activation of the immune system, production of inflammatory mediators, and migration of various cells to the site of infarction. This complex response further aggravates tissue damage by generating oxidative stress, but it eventually heals the infarction site with the formation of fibrotic tissue and left ventricle remodeling. However, the limited self-renewal capability of cardiomyocytes cannot support sufficient cardiac tissue regeneration after extensive myocardial injury, thus, leading to an irreversible decline in heart function. Approaches to improve cardiac tissue regeneration include transplantation of stem cells and delivery of inflammation modulatory and wound healing factors. Nevertheless, the harsh environment at the site of infarction, which consists of, but is not limited to, oxidative stress, hypoxia, and deficiency of nutrients, is detrimental to stem cell survival and the bioactivity of the delivered factors. The use of biomaterials represents a unique and innovative approach for protecting the loaded factors from degradation, decreasing side effects by reducing the used dosage, and increasing the retention and survival rate of the loaded cells. Biomaterials with loaded stem cells and immunomodulating and tissue-regenerating factors can be used to ameliorate inflammation, improve angiogenesis, reduce fibrosis, and generate functional cardiac tissue. In this review, we discuss recent findings in the utilization of biomaterials to enhance cytokine/growth factor and stem cell therapy for cardiac tissue regeneration in small animals with myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Functionalization of hydrogel networks with bioactive agents such as immunomodulating molecules [21], growth factors [22], and antibacterial agents [23] is a promising approach that can be used for fostering the wound repair process by the slow and sustained release of biomolecules at the wound bed.”
From 3D Printing of Thermoresponsive Hydrogel Laden with an Antimicrobial Agent towards Wound Healing Applications (2021) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.052 · Cited by 3,791
McLaughlin, S., McNeill, B., Podrebarac, J., Hosoyama, K., Sedlakova, V., Cron, G., Smyth, D., Seymour, R., Goel, K., Liang, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12748-8 · Cited by 153
VEGF-loaded microsphere patch for local protein delivery to the ischemic heart
Rodness, J., Mihic, A., Miyagi, Y., Wu, J., Weisel, R. D., & Li, R.-K. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.009 · Cited by 84
Research works printed but not linked: 124
- McClellan, 2019, Call to action, urgent challenges in cardiovascular disease, a presidential advisory from the American Heart Association, Circulation, 139, e44, 10.1161/CIR.0000000000000652 · DOI · Paper page
- Swirski, 2018, Cardioimmunology: The immune system in cardiac homeostasis and disease, Nat. Rev. Immunol., 18, 733, 10.1038/s41577-018-0065-8 · DOI · Paper page
- Saparov, 2017, Role of the immune system in cardiac tissue damage and repair following myocardial infarction, Inflamm. Res., 66, 739, 10.1007/s00011-017-1060-4 · DOI
- Andreadou, 2019, Immune cells as targets for cardioprotection, new players and novel therapeutic opportunities, Cardiovasc. Res., 115, 1117, 10.1093/cvr/cvz050 · DOI · Paper page
- Hashimoto, 2018, Therapeutic approaches for cardiac regeneration and repair, Nat. Rev. Cardiol., 15, 585, 10.1038/s41569-018-0036-6 · DOI · Paper page
- Formiga, 2016, Cardiac regeneration using growth factors, advances and challenges, Arq. Bras. Cardiol., 107, 271
- Zaghdoudi, 2016, Pro-and anti-inflammatory cytokines in post-infarction left ventricular remodeling, Int. J. Cardiol., 221, 632, 10.1016/j.ijcard.2016.07.073 · doi:10.1016/j.ijcard.2016.07.073
- Ferrini, 2019, Toward regeneration of the heart, bioengineering strategies for immunomodulation, Front. Cardiovasc. Med., 6, 26, 10.3389/fcvm.2019.00026 · DOI
- Garbayo, 2015, Heart regeneration after myocardial infarction using synthetic biomaterials, J. Control. Release, 203, 23, 10.1016/j.jconrel.2015.02.009 · DOI
- Rocker, 2020, Injectable Polymeric Delivery System for Spatiotemporal and Sequential Release of Therapeutic Proteins To Promote Therapeutic Angiogenesis and Reduce Inflammation, ACS Biomater. Sci. Eng., 6, 1217, 10.1021/acsbiomaterials.9b01758 · DOI
- Dormont, 2018, Nanoplumbers, biomaterials to fight cardiovascular diseases, Mater. Today, 21, 122, 10.1016/j.mattod.2017.07.008 · DOI
- Nurkesh, 2020, Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing, Front. Cell Dev. Biol., 8, 638, 10.3389/fcell.2020.00638 · DOI
- Saludas, 2017, Hydrogel based approaches for cardiac tissue engineering, Int. J. Pharm., 523, 454, 10.1016/j.ijpharm.2016.10.061 · DOI
- Mihic, 2015, A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function after Implantation into Myocardial Infarct, Circulation, 132, 772, 10.1161/CIRCULATIONAHA.114.014937 · DOI · Paper page
- Wang, 2018, An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction, Biomaterials, 160, 69, 10.1016/j.biomaterials.2018.01.021 · DOI · Paper page
- Maghin, 2020, Young at Heart, Combining Strategies to Rejuvenate Endogenous Mechanisms of Cardiac Repair, Front. Bioeng. Biotechnol., 8, 447, 10.3389/fbioe.2020.00447 · DOI
- Carvalho, 2015, Myocardial infarction, stem cell transplantation for cardiac regeneration, Regen. Med., 10, 1025, 10.2217/rme.15.63 · DOI
- Karantalis, 2015, Use of mesenchymal stem cells for therapy of cardiac disease, Circ. Res., 116, 1413, 10.1161/CIRCRESAHA.116.303614 · DOI · Paper page
- Shafei, 2017, Mesenchymal stem cell therapy, A promising cellbased therapy for treatment of myocardial infarction, J. Gene Med., 19, e2995, 10.1002/jgm.2995 · DOI · Paper page
- Katarzyna, 2017, Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure, an overview of evidence from the recent clinical trials, Curr. Cardiol. Rev., 13, 223, 10.2174/1573403X13666170502103833 · doi:10.2174/1573403x13666170502103833
- Bar, 2020, Inducing Endogenous Cardiac Regeneration, Can Biomaterials Connect the Dots?, Front. Bioeng. Biotechnol., 8, 126, 10.3389/fbioe.2020.00126 · DOI
- Domenech, 2016, Tissue engineering strategies for myocardial regeneration, acellular versus cellular scaffolds?, Tissue Eng. Part B Rev., 22, 438, 10.1089/ten.teb.2015.0523 · DOI
- Ashtari, 2019, Electrically conductive nanomaterials for cardiac tissue engineering, Adv. Drug Deliv. Rev., 144, 162, 10.1016/j.addr.2019.06.001 · DOI · Paper page
- Saghazadeh, 2018, Drug delivery systems and materials for wound healing applications, Adv. Drug Deliv. Rev., 127, 138, 10.1016/j.addr.2018.04.008 · DOI · Paper page
- Wang, 2017, Novel biomaterial strategies for controlled growth factor delivery for biomedical applications, NPG Asia Mater., 9, e435, 10.1038/am.2017.171 · DOI · Paper page
- Kakkar, 2017, Evolution of macromolecular complexity in drug delivery systems, Nat. Rev. Chem., 1, 1, 10.1038/s41570-017-0063 · DOI · Paper page
- Mansurov, 2018, A controlled release system for simultaneous delivery of three human perivascular stem cell-derived factors for tissue repair and regeneration, J. Tissue Eng. Regen. Med., 12, e1164, 10.1002/term.2451 · DOI
- Jimi, 2020, Sequential Delivery of Cryogel Released Growth Factors and Cytokines Accelerates Wound Healing and Improves Tissue Regeneration, Front. Bioeng. Biotechnol., 8, 345, 10.3389/fbioe.2020.00345 · DOI
- Sultankulov, B., Berillo, D., Kauanova, S., Mikhalovsky, S., Mikhalovska, L., and Saparov, A. (2019). Composite Cryogel with Polyelectrolyte Complexes for Growth Factor Delivery. Pharmaceutics, 11. · DOI
- Sultankulov, B., Berillo, D., Sultankulova, K., Tokay, T., and Saparov, A. (2019). Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine. Biomolecules, 9. · doi:10.3390/biom9090470
- Jo, 2020, Influence of PEG chain length on colloidal stability of mPEGylated polycation based coacersomes for therapeutic protein delivery, J. Ind. Eng. Chem., 82, 234, 10.1016/j.jiec.2019.10.018 · DOI
- Li, 2016, Designing hydrogels for controlled drug delivery, Nat. Rev. Mater., 1, 1, 10.1038/natrevmats.2016.71 · DOI · Paper page
- Carlini, 2019, Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction, Nat. Commun., 10, 1, 10.1038/s41467-019-09587-y · DOI
- Matsumura, 2019, Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction, Biomaterials, 217, 119289, 10.1016/j.biomaterials.2019.119289 · DOI
- Blackburn, 2015, Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction, Biomaterials, 39, 182, 10.1016/j.biomaterials.2014.11.004 · DOI
- Lister, 2016, How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction, Front. Bioeng. Biotechnol., 4, 62, 10.3389/fbioe.2016.00062 · DOI
- Li, H., Bao, M., and Nie, Y. (2020). Extracellular matrix-based biomaterials for cardiac regeneration and repair. Heart Fail. Rev. · DOI
- Firoozi, S., Pahlavan, S., Ghanian, M.H., Rabbani, S., Tavakol, S., Barekat, M., Yakhkeshi, S., Mahmoudi, E., Soleymani, M., and Baharvand, H. (2020). A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction. Biomolecules, 10. · DOI
- Cui, 2018, Polypyrrole-chitosan conductive biomaterial synchronizes cardiomyocyte contraction and improves myocardial electrical impulse propagation, Theranostics, 8, 2752, 10.7150/thno.22599 · DOI · Paper page
- Thiagarajan, 2017, Angiogenic growth factors in myocardial infarction, a critical appraisal, Heart Fail. Rev., 22, 665, 10.1007/s10741-017-9630-7 · DOI
- Frangogiannis, 2017, The extracellular matrix in myocardial injury, repair, and remodeling, J. Clin. Investig., 127, 1600, 10.1172/JCI87491 · DOI · Paper page
- Chen, 2019, Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation, Circ. Res., 125, 55, 10.1161/CIRCRESAHA.119.315069 · DOI · Paper page
- Yue, 2020, Interleukin-10 Deficiency Alters Endothelial Progenitor Cell–Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment, Circ. Res., 126, 315, 10.1161/CIRCRESAHA.119.315829 · DOI · Paper page
- Jung, 2017, IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation, Basic Res. Cardiol., 112, 33, 10.1007/s00395-017-0622-5 · DOI · Paper page
- Ferraro, 2019, Pro-angiogenic macrophage phenotype to promote myocardial repair, J. Am. Coll. Cardiol., 73, 2990, 10.1016/j.jacc.2019.03.503 · DOI · Paper page
- Cahill, 2017, Heart regeneration and repair after myocardial infarction, translational opportunities for novel therapeutics, Nat. Rev. Drug Discov., 16, 699, 10.1038/nrd.2017.106 · DOI · Paper page
- Shiraishi, 2016, Alternatively activated macrophages determine repair of the infarcted adult murine heart, J. Clin. Investig., 126, 2151, 10.1172/JCI85782 · DOI · Paper page
- Oduk, 2018, VEGF nanoparticles repair the heart after myocardial infarction, Am. J. Physiol.-Heart C, 314, H278, 10.1152/ajpheart.00471.2017 · DOI
- Hachim, 2019, Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices, J. Control. Release, 313, 131, 10.1016/j.jconrel.2019.10.018 · DOI
- Shi, 2019, Heparan sulfate proteoglycan promotes fibroblast growth factor-2 function for ischemic heart repair, Biomater. Sci., 7, 5438, 10.1039/C9BM01336A · DOI
- Fan, 2019, Myocardial-Infarction-Responsive Smart Hydrogels Targeting Matrix Metalloproteinase for On-Demand Growth Factor Delivery, Adv. Mater., 31, 1902900, 10.1002/adma.201902900 · DOI · Paper page
- Itoh, 2016, Roles of FGF signals in heart development, health, and disease, Front. Cell Dev. Biol., 4, 110
- Teringova, 2017, Apoptosis in ischemic heart disease, J. Transl. Med., 15, 87, 10.1186/s12967-017-1191-y · DOI · Paper page
- Awada, 2015, Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction, J. Control. Release, 207, 7, 10.1016/j.jconrel.2015.03.034 · DOI · Paper page
- Taimeh, 2013, Vascular endothelial growth factor in heart failure, Nat. Rev. Cardiol., 10, 519, 10.1038/nrcardio.2013.94 · DOI · Paper page
- Corti, 2017, Modulation of VEGF receptor 2 signaling by protein phosphatases, Pharmacol. Res., 115, 107, 10.1016/j.phrs.2016.11.022 · DOI
- Cassani, 2020, Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration, The Pulsing Heart of Advanced Therapies, Front. Bioeng. Biotechnol., 8, 323, 10.3389/fbioe.2020.00323 · DOI
- Catoira, 2019, Overview of natural hydrogels for regenerative medicine applications, J. Mater. Sci. Mater. Med., 30, 115, 10.1007/s10856-019-6318-7 · DOI · Paper page
- Gyles, 2017, A review of the designs and prominent biomedical advances of natural and synthetic hydrogel formulations, Eur. Polym. J., 88, 373, 10.1016/j.eurpolymj.2017.01.027 · DOI · Paper page
- Rufaihah, 2017, Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction, Acta Biomater., 58, 102, 10.1016/j.actbio.2017.06.009 · DOI
- Navaei, 2016, PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering, Acta Biomater., 32, 10, 10.1016/j.actbio.2015.12.019 · DOI
- Yuan, 2019, Injectable citrate-based hydrogel as an angiogenic biomaterial improves cardiac repair after myocardial infarction, ACS Appl. Mater. Interfaces, 11, 38429, 10.1021/acsami.9b12043 · DOI
- Waters, 2018, Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue, Acta Biomater., 69, 95, 10.1016/j.actbio.2017.12.025 · DOI · Paper page
- Ho, 2016, Nanoparticle drug delivery systems and their use in cardiac tissue therapy, Nanomedicine, 11, 693, 10.2217/nnm.16.6 · DOI
- Nguyen, 2015, Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction, Adv. Mater., 27, 5547, 10.1002/adma.201502003 · DOI · Paper page
- Somasuntharam, 2016, Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction, Biomaterials, 83, 12, 10.1016/j.biomaterials.2015.12.022 · DOI
- Qi, 2017, Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction, Int. J. Nanomed., 12, 4835, 10.2147/IJN.S132064 · DOI
- Steele, 2020, Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal model, Cytokine, 127, 154974, 10.1016/j.cyto.2019.154974 · DOI
- Park, 2019, Cardiac fibrosis, potential therapeutic targets, Transl. Res., 209, 121, 10.1016/j.trsl.2019.03.001 · DOI · Paper page
- Lin, 2019, A viscoelastic adhesive epicardial patch for treating myocardial infarction, Nat. Biomed. Eng., 3, 632, 10.1038/s41551-019-0380-9 · DOI · Paper page
- Wan, 2017, Human heart valve-derived scaffold improves cardiac repair in a murine model of myocardial infarction, Sci. Rep., 7, 1
- Fan, 2020, CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice, J. Mol. Cell. Cardiol., 141, 1, 10.1016/j.yjmcc.2020.03.003 · DOI
- Donndorf, 2013, Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease, Curr. Pharm. Biotechnol., 14, 12
- Saparov, 2013, The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair, Int. J. Mol. Sci., 14, 16258, 10.3390/ijms140816258 · DOI
- Luo, 2017, Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice, Circ. Res., 120, 1768, 10.1161/CIRCRESAHA.116.310374 · DOI · Paper page
- Chang, M.L., Chiu, Y.J., Li, J.S., Cheah, K.P., and Lin, H.H. (2020). Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction. J. Clin. Med., 9. · doi:10.3390/jcm9051277
- Chen, 2013, Human pericytes for ischemic heart repair, Stem cells, 31, 305, 10.1002/stem.1285 · DOI · Paper page
- Jiang, 2020, Heart regeneration with human pluripotent stem cells, Prospects and challenges, Bioact. Mater., 5, 74
- Parizadeh, 2019, Stem cell therapy, A novel approach for myocardial infarction, J. Cell. Physiol., 234, 16904, 10.1002/jcp.28381 · DOI
- Higuchi, 2017, Stem cell therapies for myocardial infarction in clinical trials, bioengineering and biomaterial aspects, Lab. Investig., 97, 1167, 10.1038/labinvest.2017.100 · DOI
- Karantalis, 2014, Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting, the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial, Circ. Res., 114, 1302, 10.1161/CIRCRESAHA.114.303180 · DOI · Paper page
- Luger, 2017, Intravenously delivered mesenchymal stem cells, systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy, Circ. Res., 120, 1598, 10.1161/CIRCRESAHA.117.310599 · DOI · Paper page
- Bao, 2017, C-Kit Positive cardiac stem cells and bone marrow–derived mesenchymal stem cells synergistically enhance angiogenesis and improve cardiac function after myocardial infarction in a paracrine manner, J. Card. Fail., 23, 403, 10.1016/j.cardfail.2017.03.002 · DOI
- Kanda, 2017, Cellular mechanisms underlying cardiac engraftment of stem cells, Expert Opin. Biol. Ther., 17, 1127, 10.1080/14712598.2017.1346080 · DOI
- Yao, 2018, Potentials of combining nanomaterials and stem cell therapy in myocardial repair, Nanomedicine (Lond), 13, 1623, 10.2217/nnm-2018-0013 · DOI
- Amer, 2016, A detailed assessment of varying ejection rate on delivery efficiency of mesenchymal stem cells using narrow-bore needles, Stem cells Transl. Med., 5, 366, 10.5966/sctm.2015-0208 · DOI
- Aguado, 2012, Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers, Tissue Eng. Part A, 18, 806, 10.1089/ten.tea.2011.0391 · DOI · Paper page
- Park, 2020, Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction, J. Control. Release, 321, 602, 10.1016/j.jconrel.2020.02.047 · DOI
- Chen, 2020, Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice, J. Am. Heart Assoc., 9, e013784, 10.1161/JAHA.119.013784 · DOI
- Blocki, 2015, Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium, Biomaterials, 53, 12, 10.1016/j.biomaterials.2015.02.075 · DOI
- Gallagher, 2020, Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions, Acta Biomater., 107, 78, 10.1016/j.actbio.2020.02.043 · DOI
- Chow, 2017, Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction, Stem Cell Rep., 9, 1415, 10.1016/j.stemcr.2017.09.003 · DOI
- Cai, 2019, Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction, Faseb J., 33, 8306, 10.1096/fj.201801768RR · DOI
- Harel, 2017, NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells, Vasc. Pharm., 92, 22, 10.1016/j.vph.2017.03.002 · DOI
- Lee, 2018, Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix, Nat. Biomed. Eng., 2, 104, 10.1038/s41551-018-0191-4 · DOI
- Ottersbach, 2018, Improved heart repair upon myocardial infarction, Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes, Biomaterials, 155, 176, 10.1016/j.biomaterials.2017.11.012 · DOI
- Choe, 2019, Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels, Mesenchymal stem cell encapsulation and regeneration of infarcted hearts, Biomaterials, 225, 119513, 10.1016/j.biomaterials.2019.119513 · DOI · Paper page
- Kai, 2014, Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model, Acta. Biomater., 10, 2727, 10.1016/j.actbio.2014.02.030 · DOI
- Wang, 2017, Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium, J. Cell Mol. Med., 21, 1751, 10.1111/jcmm.13097 · DOI
- Chen, 2018, Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats, Acta. Biomater., 80, 154, 10.1016/j.actbio.2018.09.013 · DOI · Paper page
- Gaetani, 2015, Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction, Biomaterials, 61, 339, 10.1016/j.biomaterials.2015.05.005 · DOI · Paper page
- Su, 2018, Cardiac Stem Cell Patch Integrated with Microengineered Blood Vessels Promotes Cardiomyocyte Proliferation and Neovascularization after Acute Myocardial Infarction, ACS Appl. Mater. Interfaces, 10, 33088, 10.1021/acsami.8b13571 · DOI
- Dong, 2020, Engineered bioactive nanoparticles incorporated biofunctionalized ECM/silk proteins based cardiac patches combined with MSCs for the repair of myocardial infarction, In vitro and in vivo evaluations, Sci. Total Environ., 707, 135976, 10.1016/j.scitotenv.2019.135976 · DOI
- Gao, 2017, Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold, Circ. Res., 120, 1318, 10.1161/CIRCRESAHA.116.310277 · DOI · Paper page
- Tang, 2018, Cardiac cell-integrated microneedle patch for treating myocardial infarction, Sci. Adv., 4, eaat9365, 10.1126/sciadv.aat9365 · DOI · Paper page
- Park, 2019, Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction, Nat. Commun., 10, 3123, 10.1038/s41467-019-11091-2 · DOI · Paper page
- Yeung, 2019, Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo, J. Tissue Eng. Regen. Med., 13, 2031, 10.1002/term.2954 · DOI
- Melhem, 2017, 3D Printed Stem-Cell-Laden, Microchanneled Hydrogel Patch for the Enhanced Release of Cell-Secreting Factors and Treatment of Myocardial Infarctions, ACS Biomater. Sci. Eng., 3, 1980, 10.1021/acsbiomaterials.6b00176 · DOI
- Mayfield, 2014, The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function, Biomaterials, 35, 133, 10.1016/j.biomaterials.2013.09.085 · DOI
- Ahmadi, 2015, PET imaging of a collagen matrix reveals its effective injection and targeted retention in a mouse model of myocardial infarction, Biomaterials, 49, 18, 10.1016/j.biomaterials.2015.01.016 · doi:10.1016/j.biomaterials.2015.01.016
- Han, 2015, Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells’ therapeutic efficacy for myocardial infarction, ACS Nano, 9, 2805, 10.1021/nn506732n · DOI
- Lemcke, 2017, Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells, Sci. Rep., 7, 9755, 10.1038/s41598-017-10122-6 · doi:10.1038/s41598-017-10122-6
- Marcu, 2015, Functional Characterization and Comparison of Intercellular Communication in Stem Cell-Derived Cardiomyocytes, Stem Cells, 33, 2208, 10.1002/stem.2009 · DOI
- Sottas, 2018, Improving electrical properties of iPSC-cardiomyocytes by enhancing Cx43 expression, J. Mol. Cell Cardiol., 120, 31, 10.1016/j.yjmcc.2018.05.010 · DOI
- Liang, 2019, Conductive Hydrogen Sulfide-Releasing Hydrogel Encapsulating ADSCs for Myocardial Infarction Treatment, ACS Appl. Mater. Interfaces, 11, 14619, 10.1021/acsami.9b01886 · DOI
- Tang, 2018, Targeted repair of heart injury by stem cells fused with platelet nanovesicles, Nat. Biomed. Eng., 2, 17, 10.1038/s41551-017-0182-x · DOI · Paper page
- Yokoyama, 2019, Cardiac Regeneration by Statin-Polymer Nanoparticle-Loaded Adipose-Derived Stem Cell Therapy in Myocardial Infarction, Stem Cells Transl. Med., 8, 1055, 10.1002/sctm.18-0244 · DOI
- Yao, 2015, Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction, Biomaterials, 60, 130, 10.1016/j.biomaterials.2015.04.046 · DOI · Paper page
- Saludas, 2017, Transplantation of adipose-derived stem cells combined with neuregulin-microparticles promotes efficient cardiac repair in a rat myocardial infarction model, J. Control. Release, 249, 23, 10.1016/j.jconrel.2017.01.026 · DOI
- Chung, 2015, Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction, J. Control. Release, 205, 218, 10.1016/j.jconrel.2015.02.013 · DOI
- Kumar, 2016, Animal models of myocardial infarction, mainstay in clinical translation, Regul. Toxicol. Pharmacol., 76, 221, 10.1016/j.yrtph.2016.03.005 · DOI
- Zaragoza, 2011, Animal models of cardiovascular diseases, J. Biomed. Biotechnol., 2011, 497841, 10.1155/2011/497841 · DOI · Paper page
- Seyhan, 2019, Lost in translation, the valley of death across preclinical and clinical divide–identification of problems and overcoming obstacles, Transl. Med. Commun., 4, 1, 10.1186/s41231-019-0050-7 · DOI · Paper page
- Camacho, 2016, Small mammalian animal models of heart disease, Am. J. Cardiovasc. Dis., 6, 70
Cited by
Chitosan-Based Biomaterials for Tissue Regeneration
Kim, Y., Zharkinbekov, Z., Raziyeva, K., Tabyldiyeva, L., Berikova, K., Zhumagul, D., Temirkhanova, K., & Saparov, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030807 · Cited by 264
Self-citationSynthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine
Marchini, A., & Gelain, F. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1932716 · Cited by 91
Nizioł, M., Paleczny, J., Junka, A., Shavandi, A., Dawiec-Liśniewska, A., & Podstawczyk, D. (2021) · Bioengineering · doi:10.3390/bioengineering8060079 · Cited by 85
Metadata
- Authors
- Smagul, S., Kim, Y., Smagulova, A., Raziyeva, K., Nurkesh, A., & Saparov, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-19
- Volume
- 21
- Issue
- 17
- Pages
- 5952
- ISSN
- 1422-0067
- Cited by
- 64
- References
- 4
- Language
- en
- Funders
- Ministry of Education and Science (АР05135207)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. https://app.cochat.ai/papers/10.3390/ijms21175952
- The paper
- Smagul, S., Kim, Y., Smagulova, A., Raziyeva, K., Nurkesh, A., & Saparov, A. (2020). Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21175952
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.